The global paediatric HIV epidemic is shifting into a new phase as children on antiretroviral
therapy (ART) move into adolescence and adulthood, and face new challenges of living with …

Background: Having 90% of patients on antiretroviral therapy (ART) and achieving an
undetectable viral load (VL) is 1 of the 90: 90: 90 by 2020 targets. In this global analysis, we …

Partnerships between researchers and policymakers can improve uptake and integration of
scientific evidence. This article describes the research-policy partnership between the …

Background: There is limited knowledge about the optimal timing of antiretroviral treatment
initiation in older children and adolescents. Methods: A total of 20 576 antiretroviral …

Background: The CD4 cell count or percent (CD4%) at the start of combination antiretroviral
therapy (cART) is an important prognostic factor in children starting therapy and an important …

Introduction HIV care and treatment programmes worldwide are transforming as they push to
deliver universal access to essential prevention, care and treatment services to persons …

Background: Globally, 49% of the estimated 1.8 million children living with HIV are
accessing antiretroviral therapy (ART). There are limited data concerning long-term …

Background: Loss to follow-up (LTFU) challenges the success of antiretroviral therapy (ART)
scale-up among pediatric patients. Little is known about children who drop out of care. We …

Introduction Timely descriptions of HIV service characteristics and their evolution over time
across diverse settings are important for monitoring the scale-up of evidence-based program …

Background: There are few validated tools to measure stigma, particularly among children
living with HIV and their families. Methods: This study was nested within a larger study that …